{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T01:11:44Z","timestamp":1792890704190,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T00:00:00Z","timestamp":1737417600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.jgar.2025.01.009","type":"journal-article","created":{"date-parts":[[2025,1,25]],"date-time":"2025-01-25T00:18:12Z","timestamp":1737764292000},"page":"216-223","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Clinical and molecular characteristics of KPC-producing Klebsiella pneumoniae bloodstream infections: Results of a multicentre study"],"prefix":"10.1016","volume":"41","author":[{"given":"Lucia","family":"Brescini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-8075-7996","authenticated-orcid":false,"given":"Gloria","family":"D'Achille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5427-8011","authenticated-orcid":false,"given":"Chiara","family":"Papalini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Pallotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Teodori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donatella","family":"Pietrella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Mencacci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedetta","family":"Canovari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Pieretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Mingoia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Montalti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0772-0214","authenticated-orcid":false,"given":"Gianluca","family":"Morroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Bruna","family":"Pasticci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Barchiesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgar.2025.01.009_bib0001","unstructured":"World Health Organization. WHO priority pathogens list for R&D of New antibiotics, https:\/\/www.who.int\/news\/item\/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed; 2017 [accessed 10.01.2024]."},{"issue":"3","key":"10.1016\/j.jgar.2025.01.009_bib0002","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3390\/antibiotics8030122","article-title":"Present and future of carbapenem-resistant Enterobacteriaceae (CRE) infections","volume":"8","author":"Suay-Garc\u00eda","year":"2019","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.jgar.2025.01.009_bib0003","unstructured":"European Centre for Disease Prevention and Control. Surveillance of antimicrobials resistance in Europe, 2020 data, https:\/\/www.ecdc.europa.eu\/en\/publications-data\/antimicrobial-resistance-surveillance-europe-2022-2020-data; 2022 [accessed 10.01.2024]."},{"key":"10.1016\/j.jgar.2025.01.009_bib0004","doi-asserted-by":"crossref","unstructured":"Girmenia C, Serrao A, Canichella M. Epidemiology of carbapenem resistant Klebsiella pneumoniae infections in Mediterranean countries. Mediterr J Hematol Infect Dis 2016;8:e2016032. doi: 10.4084\/MJHID.2016.032.","DOI":"10.4084\/mjhid.2016.032"},{"key":"10.1016\/j.jgar.2025.01.009_bib0005","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1093\/jac\/dkv086","article-title":"Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study","volume":"70","author":"Tumbarello","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2025.01.009_bib0006","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13054-020-2742-9","article-title":"Time to appropriate antibiotic therapy is a predictor of outcome in patients with bloodstream infection caused by KPC-producing Klebsiella pneumoniae","volume":"24","author":"Falcone","year":"2020","journal-title":"Crit Care"},{"key":"10.1016\/j.jgar.2025.01.009_bib0007","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jinf.2018.02.007","article-title":"Mortality due to KPC carbapenemase-producing Klebsiella pneumoniae infections: Systematic review and meta-analysis","volume":"76","author":"Ramos-Casta\u00f1eda","year":"2018","journal-title":"J Infect"},{"key":"10.1016\/j.jgar.2025.01.009_bib0008","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.688989","article-title":"Clinical and bacterial characteristics of Klebsiella pneumoniae affecting 30-day mortality in patients with bloodstream infection","volume":"11","author":"Wu","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.jgar.2025.01.009_bib0009","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1186\/s12879-018-3263-x","article-title":"Bloodstream infections caused by Klebsiella pneumoniae: prevalence of blaKPC, virulence factors and their impacts on clinical outcome","volume":"18","author":"Xu","year":"2018","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jgar.2025.01.009_bib0010","article-title":"Retrospective observational study from a Chinese network of the impact of combination therapy versus monotherapy on mortality from carbapenem-resistant Enterobacteriaceae bacteremia","volume":"63","author":"Wang","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2025.01.009_bib0011","first-page":"1079","article-title":"Reduced mortality from KPC-K.pneumoniae bloodstream infection in high-risk patients with hematological malignancies colonized by KPC-K.pneumoniae","volume":"21","author":"Micozzi","year":"2021","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jgar.2025.01.009_bib0012","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1016\/j.jfma.2021.04.014","article-title":"Healthcare-associated carbapenem-resistant Klebsiella pneumoniae bloodstream infections: risk factors, mortality, and antimicrobial susceptibility, 2017-2019","volume":"120","author":"Hsu","year":"2021","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.jgar.2025.01.009_bib0013","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1093\/cid\/ciy492","article-title":"Efficacy of ceftazidime-avibactam salvage therapy in patients with infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae","volume":"68","author":"Tumbarello","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2025.01.009_bib0014","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s15010-021-01577-x","article-title":"Mono vs. combo regimens with novel beta-lactam\/beta-lactamase inhibitor combinations for the treatment of infections due to carbapenemase-producing enterobacterales: Insights from the literature","volume":"49","author":"Meini","year":"2021","journal-title":"Infection"},{"key":"10.1016\/j.jgar.2025.01.009_bib0015","unstructured":"ECDC. Surveillance Atlas of Infectious Diseases. https:\/\/atlas.ecdc.europa.eu\/public\/index.aspx?Dataset=27&HealthTopic=4. [accessed 10.01.2024]."},{"key":"10.1016\/j.jgar.2025.01.009_bib0016","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1038\/s41564-019-0492-8","article-title":"Epidemic of carbapenem-resistant Klebsiella pneumoniae in Europe is driven by nosocomial spread","volume":"4","author":"David","year":"2019","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.jgar.2025.01.009_bib0017","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1093\/jac\/dkaa431","article-title":"The changing epidemiology of carbapenemase-producing Klebsiella pneumoniae in Italy: toward polyclonal evolution with emergence of high-risk lineages","volume":"76","author":"Di Pilato","year":"2021","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2025.01.009_bib0018","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"10.1016\/j.jgar.2025.01.009_bib0019","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jgar.2025.01.009_bib0020","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2018.23.30.1700775","article-title":"Epidemiology and resistance phenotypes of carbapenemase-producing Klebsiella pneumoniae in Greece, 2014 to 2016","volume":"23","author":"Galani","year":"2018","journal-title":"Euro Surveill"},{"key":"10.1016\/j.jgar.2025.01.009_bib0021","unstructured":"The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 14.0, 2024, http:\/\/www.eucast.org; 2024 [accessed 10.01.2024]."},{"issue":"9","key":"10.1016\/j.jgar.2025.01.009_bib0022","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1128\/jcm.33.9.2233-2239.1995","article-title":"Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: Criteria for bacterial strain typing","volume":"33","author":"Tenover","year":"1995","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jgar.2025.01.009_bib0023","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1093\/jac\/dkx197","article-title":"pHT\u03b2-promoted mobilization of non-conjugative resistance plasmids from Enterococcus faecium to Enterococcus faecalis","volume":"72","author":"Di Sante","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2025.01.009_bib0024","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/jac\/dkaa503","article-title":"Ceftazidime\/avibactam in the era of carbapenemase-producing Klebsiella pneumoniae: Experience from a national registry study","volume":"76","author":"Karaiskos","year":"2021","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2025.01.009_bib0025","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1093\/cid\/cis588","article-title":"Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: Importance of combination therapy","volume":"55","author":"Tumbarello","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2025.01.009_bib0026","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1128\/AAC.02166-13","article-title":"Carbapenemase-producing Klebsiella pneumoniae bloodstream infections: Lowering mortality by antibiotic combination schemes and the role of carbapenems","volume":"58","author":"Daikos","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2025.01.009_bib0027","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1186\/s12879-019-4268-9","article-title":"Clinical and epidemiological characteristics of KPC-producing Klebsiella pneumoniae from bloodstream infections in a tertiary referral center in Italy","volume":"19","author":"Brescini","year":"2019","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jgar.2025.01.009_bib0028","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.cmi.2016.01.016","article-title":"Predictors of outcome in ICU patients with septic shock caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae","volume":"22","author":"Falcone","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jgar.2025.01.009_bib0029","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00883-17","article-title":"Ceftazidime-Avibactam is superior to other treatment regimens against carbapenem-resistant Klebsiella pneumoniae bacteremia","volume":"61","author":"Shields","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2025.01.009_bib0030","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1093\/cid\/cix783","article-title":"Colistin versus ceftazidime-avibactam in the treatment of infections due to carbapenem-resistant Enterobacteriaceae","volume":"66","author":"van Duin","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2025.01.009_bib0031","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1093\/jac\/dkac049","article-title":"Impact of ceftazidime\/avibactam versus best available therapy on mortality from infections caused by carbapenemase-producing Enterobacterales (CAVICOR study)","volume":"77","author":"Cast\u00f3n","year":"2022","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2025.01.009_bib0032","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1093\/cid\/ciab176","article-title":"Ceftazidime-avibactam use for Klebsiella pneumoniae carbapenemase-producing K. pneumoniae infections: A retrospective observational multicenter study","volume":"73","author":"Tumbarello","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2025.01.009_bib0033","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s10096-023-04577-x","article-title":"Rapid diagnostics and ceftazidime\/avibactam for KPC-producing Klebsiella pneumoniae bloodstream infections: Impact on mortality and role of combination therapy","volume":"42","author":"Boattini","year":"2023","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jgar.2025.01.009_bib0034","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3390\/microorganisms12010195","article-title":"Ceftazidime-avibactam improves outcomes in high-risk neutropenic patients with Klebsiella pneumoniae carbapenemase-producing enterobacterales bacteremia","volume":"12","author":"Herrera","year":"2024","journal-title":"Microorganisms"},{"key":"10.1016\/j.jgar.2025.01.009_bib0035","article-title":"Diversity, virulence, and antimicrobial resistance of the KPC-producing Klebsiella pneumoniae ST307 clone","volume":"3","author":"Villa","year":"2017","journal-title":"Microb Genom"},{"key":"10.1016\/j.jgar.2025.01.009_bib0036","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01148-20","article-title":"Emerging antimicrobial-resistant high-risk Klebsiella pneumoniae clones ST307 and ST147","volume":"64","author":"Peirano","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2025.01.009_bib0037","doi-asserted-by":"crossref","first-page":"703","DOI":"10.2217\/fmb-2020-0246","article-title":"High prevalence of carbapenem-resistant Klebsiella pneumoniae ST307 recovered from fecal samples in an Italian hospital","volume":"16","author":"Magi","year":"2021","journal-title":"Future Microbiol"},{"key":"10.1016\/j.jgar.2025.01.009_bib0038","article-title":"Population structure of KPC carbapenemase-producing Klebsiella pneumoniae in a long-term acute-care rehabilitation facility: Identification of a new lineage of clonal group 101, associated with local hyperendemicity","volume":"6","author":"Arena","year":"2020","journal-title":"Microb Genom"},{"key":"10.1016\/j.jgar.2025.01.009_bib0039","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00447-22","article-title":"Klebsiella pneumoniae carbapenemase variants resistant to ceftazidime-avibactam: An evolutionary overview","volume":"66","author":"Hobson","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2025.01.009_bib0040","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00574-21","article-title":"Evolutionary trajectories toward ceftazidime-avibactam resistance in Klebsiella pneumoniae clinical isolates","volume":"65","author":"Carattoli","year":"2021","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716525000207?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716525000207?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T13:09:48Z","timestamp":1741352988000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213716525000207"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":40,"alternative-id":["S2213716525000207"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2025.01.009","relation":{},"ISSN":["2213-7165"],"issn-type":[{"value":"2213-7165","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical and molecular characteristics of KPC-producing Klebsiella pneumoniae bloodstream infections: Results of a multicentre study","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2025.01.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy.","name":"copyright","label":"Copyright"}]}}